J. BousquetJ. FarrellG. CrooksP. HellingsE. H. BelM. BewickN. H. ChavannesJ. Correia De SousaA. A. CruzT. HaahtelaG. JoosN. KhaltaevJ. MalvaA. MuraroM. NoguesS. PalkonenS. PedersenC. Robalo-CordeiroB. SamolinskiT. StrandbergA. ValiulisA. YorganciogluT. ZuberbierA. BedbrookW. AbererM. AdachiA. AgustiC. A. AkdisM. AkdisJ. AnkriA. AlonsoI. Annesi-MaesanoI. J. AnsoteguiJ. M. AntoS. ArnavielheH. ArshadC. BaiI. BaiardiniC. BachertA. K. BaigenzhinC. BarbaraE. D. BatemanB. BeghéA. Ben KhederK. S. BennoorM. BensonK. C. BergmannT. BieberC. Bindslev-JensenL. BjermerH. BlainF. BlasiA. L. BonerM. BoniniS. BoniniS. Bosnic-AnticevitchL. P. BouletR. BourretP. J. BousquetF. BraidoA. H. BriggsC. E. BrightlingJ. BrozekR. BuhlP. G. BurneyA. BushF. Caballero-FonsecaD. CaimmiM. A. CalderonCHU MontpellierMACVIA-LRVieillissement et Maladies Chroniques. Approches Epidemiologiques et de Sante PubliqueUniversite de Versailles Saint-Quentin-en-YvelinesDepartment of HealthNational Health ServiceKU LeuvenEuropean Academy of Allergy and Clinical ImmunologyAcademic Medical Centre, University of AmsterdamEuropean Respiratory SocietyiQ4U Consultants LtdLeiden University Medical Center - LUMCGlobal Alliance Against Chronic Respiratory Diseases (GARD)International Primary Care Respiratory GroupUniversidade do Minho, Escola de Ciencias da SaudeUniversidade Federal da BahiaGARD Executive CommitteeEIP on AHA Commitment for ActionSkin and Allergy HospitalUniversity Hospital of GhentUniversidade de Coimbra, Faculdade de MedicinaAgeingatCoimbra Reference SiteAzienda Ospedaliera Di PadovaCaisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR)EFA European Federation of Allergy and Airways Diseases Patients' AssociationsSyddansk UniversitetCentro Hospitalar e Universitario de CoimbraMedical University of WarsawHelsingin YliopistoOulun YliopistoEuropean UnionVilniaus universitetasEuropean Academy of Paediatrics (EAP/UEMS-SP)Celal Bayar UniversitesiTurkish Thoracic SocietyCharité – Universitätsmedizin BerlinSecretary General of the Global Allergy and Asthma European Network (GA2LEN)Medizinische Universitat GrazInternational University of Health and WelfareUniversitat de BarcelonaCentro de Investigacion Biomedica en Red de Enfermedades RespiratoriasUniversity of ZurichInsermClinica QuironCentre de Recerca en Epidemiologia Ambiental, BarcelonaHospital del MarCIBER Epidemiologia Y Salud PublicaUniversitat Pompeu Fabra BarcelonaDigi HealthDavid Hide Asthma and Allergy Research CentreChinese Medical AssociationOspedale Policlinico San MartinoEuroAsian Respiratory SocietyFaculdade de Medicina, Universidade de LisboaUniversity of Cape TownUniversita degli Studi di Modena e Reggio EmiliaUniversite de Tunis El Manar, Hopital Abderrahmene MamiNational Institute of Diseases of the Chest and HospitalLinköpings universitetUniversität BonnOdense UniversitetshospitalSkånes universitetssjukhusCentre Européen de Recherche sur le Mouvement Humain, Université de MontpellierUniversità degli Studi di MilanoUniversità degli Studi di VeronaUniversità degli Studi di Roma La SapienzaUniversità degli Studi della Campania Luigi VanvitelliThe University of SydneyUniversité LavalUniversity of GlasgowUniversity Hospitals of Leicester NHS TrustUniversity of LeicesterMcMaster University, Faculty of Health SciencesJohannes Gutenberg Universität MainzNational Heart and Lung InstituteGlaxoSmithKline plc.Medical Research CouncilRoyal Brompton HospitalCentro Medico Docente La TrinidadUniversity of LiverpoolUniversidade Federal de Minas GeraisRégion Languedoc RoussillonOslo University HospitalAllergy & Asthma Associates of Southern CaliforniaRegional Ministry of EqualityUniversity of South Florida, TampaUniversidad Simón BolívarAsma e ImmunologiaPanepistimio KritisCapital Institute of PediatricsTbilisi State Medical UniversityPulmonolory Research Institute FMBALatvian Psychiatric AssociationNova Southeastern UniversityImperial College LondonKarolinska InstitutetTechnical University of MunichCHU StrasbourgEUREGHAUniversity of EdinburghUniversitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-NapocaKronikguneSorbonne Universite2018-12-112019-03-142018-12-112019-03-142016-07-29Clinical and Translational Allergy. Vol.6, No.1 (2016)204570222-s2.0-85006427875https://repository.li.mahidol.ac.th/handle/20.500.14594/40774© 2016 The Author(s). Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.Mahidol UniversityImmunology and MicrobiologyMedicineReviewSCOPUS10.1186/s13601-016-0116-9